Mutation Spectrum and Birth Prevalence of Inborn Errors of Metabolism among Emiratis: A study from Tawam Hospital Metabolic Center, United Arab Emirates
- PMID: 24516753
- PMCID: PMC3916276
- DOI: 10.12816/0003335
Mutation Spectrum and Birth Prevalence of Inborn Errors of Metabolism among Emiratis: A study from Tawam Hospital Metabolic Center, United Arab Emirates
Abstract
Objectives: This study aimed to determine the mutation spectrum and prevalence of inborn errors of metabolism (IEM) among Emiratis.
Methods: The reported mutation spectrum included all patients who were diagnosed with IEM (excluding those with lysosomal storage diseases [LSD]) at Tawam Hospital Metabolic Center in Abu Dhabi, United Arab Emirates, between January 1995 and May 2013. Disease prevalence (per 100,000 live births) was estimated from data available for 1995-2011.
Results: In 189 patients, 57 distinct IEM were diagnosed, of which 20 (35%) entities were previously reported LSD (65 patients with 39 mutations), with a birth prevalence of 26.87/100,000. This study investigated the remaining 37 (65%) patients with other IEM (124 patients with 62 mutations). Mutation analysis was performed on 108 (87%) of the 124 patients. Five patients with biotinidase deficiency had compound heterozygous mutations, and two siblings with lysinuric protein intolerance had two homozygous mutations. The remaining 103 (95%) patients had homozygous mutations. As of this study, 29 (47%) of the mutations have been reported only in Emiratis. Two mutations were found in three tribes (biotinidase deficiency [BTD, c.1330G>C] and phenylketonuria [PAH, c.168+5G>C]). Two mutations were found in two tribes (isovaleric aciduria [IVD, c.1184G>A] and propionic aciduria [PCCB, c.990dupT]). The remaining 58 (94%) mutations were each found in individual tribes. The prevalence was 48.37/100,000. The most prevalent diseases (2.2-4.9/100,000) were biotinidase deficiency; tyrosinemia type 1; phenylketonuria; propionic aciduria; glutaric aciduria type 1; glycogen storage disease type Ia, and mitochondrial deoxyribonucleic acid depletion.
Conclusion: The IEM birth prevalence (LSD and non-LSD) was 75.24/100,000. These results justify implementing prevention programmes that incorporate genetic counselling and screening.
Keywords: Founder Effect; Metabolism, Inborn Errors; Mutations; Prevalence; United Arab Emirates.
References
-
- Teebi AS, editor. Genetic Disorders Among Arab Populations. 2nd ed. New York: Springer; 2010. p. 612.
-
- Al-Gazali L, Ali BR. Mutations of a country: A mutation review of single gene disorders in the United Arab Emirates (UAE) Hum Mutat. 2010;31:505–20. - PubMed
-
- United Arab Emirates National Bureau of Statistics Methodology of estimating the population in UAE. From: www.uaestatistics.gov.ae/ReportPDF/Population%20Estimates%202006%20-%202... Accessed: August 2013.
-
- United Arab Emirates National Bureau of Statistics Health 2011. From: www.uaestatistics.gov.ae/EnglishHome/ReportDetailsEnglish/tabid/121/Defa... Accessed: Aug 2013.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous